Australia's most trusted
source of pharma news
Tuesday, 21 July 2026
Tuesday, 21 July 2026
Subscribe
Login
Who's to blame for pharma bottlenecks?
A deep dive into pharma leadership across ANZ has uncovered who's to blame for company bottlenecks and the different approach being taken by high-performing companies.
Talent moving on... and up
As company workforces continue to change shape, hiring and promotion of top talent remains. See who's scored a new role
TODAY
Pharmas face First Nations flak
Industry in the hot seat with questions over disease awareness campaigns and sponsored events featuring women of colour
TODAY
Another ANZ GM departs
After two-and-a-half years in the top job, this ANZ General Manager will be leaving the role at the end of the month
20 July
17 drugs eye August listing
Twelve of the 17 drugs jumped on the wait list after reaching the last stage before PBS listing occurs in June
20 July
Why Lilly turned down PBS listing
PSDs have revealed the roadblock that Lilly and the PBAC could not pass in arriving at an agreement to subsidise Mounjaro for diabetes
20 July
Who's the new Novartis Country Head?
One month after its Country President stepped down, Novartis has announced a new national leader
17 July
Latest Jobs
Head of Unlicensed MedicinesQuality AssociateBD Lead APACSenior Quality EngineerWarehouse AssistantClinical Research AssociateCustomer Service RepresentativeMedical Science Liaison36 more...
Pharma in Focus Jobs
Marketing & Communications (1)
Sales & Customer Relations (19)
- Customer Service Representative - Macquarie Park
- Customer Service Representative - Sydney
- Medical Sales Representative - Sydney
- Territory Manager - Newcastle
- Logistics and Customer Service Specialist - Belrose
- Customer Service Representative - Keysborough
- Customer Service Administrator - East Ryde
- Customer Service Representative - Warriewood
- Customer Service Representative - Perth
- Inside Sales Specialist - Brisbane
- Inside Sales Specialist - Melbourne
- Inside Sales Specialist - Sydney
- Customer Service Representative - Frenchs Forest
- Territory Manager - Melbourne
- Territory Manager - Auckland
- Customer Service Representative - Melbourne
- Territory Manager - Sydney
- Customer Service Representative - Macquarie Park
- Territory Manager - Sterilisation - Melbourne
Access & Reimbursement (1)
Clinical & Medical, R&D (8)
- Clinical Research Associate - Sydney
- Medical Science Liaison - Sydney
- Medical Sales Representative - Sydney
- Clinical Research Associate II - Melbourne
- Clinical Trial Study Start Up Specialist - Melbourne
- Clinical Trial Investigator - Sutherland
- Senior Medical Receptionist - 2IC - Western Australia
- Clinical Trial Investigator - Melbourne
Regulatory, Pharmacovigilance & QA (4)
- Quality Associate - Sydney
- Senior Quality Engineer - Tullamarine
- Regulatory Affairs Manager - Belrose
- Senior Quality Assurance Associate - Randwick
Other (13)
- Head of Unlicensed Medicines - Sydney
- BD Lead APAC - Australia, Melbourne Preferred (Remote – Flexible)
- Warehouse Assistant - North Ryde
- Senior Payroll Specialist - Macquarie Park
- Distribution Clerk - Warehousing - Jacana
- Commercial Specialist - Brisbane
- Logistics Planner - North Ryde
- Warehouse Assistant - Eight Mile Plains
- Warehouse Assistant - Macquarie Park
- Pharmacy Assistant - Toongabbie
- Loan Kit Technician - Macquarie Park
- Finance Business Partner - North Ryde
- HR Consultant - Melbourne
18 drugs 'missing' from the PBS
Which drugs have been named in a new report, that blames the Govt's torturous reimbursement process for the failure to win a listing
20 July
New GM to drive market expansion
After leaving J&J, this new boss has been tasked with growing the ANZ market and she is hitting the ground running
20 July
Second generic targets $53M drug
The TGA has approved a raft of generics targeting PBS listed drugs, sponsored by six pharmaceutical companies
20 July Approvals Action
Ali Rossiter lands new appointment
Exactly a month after resigning from her role as Novartis ANZ boss, Rossiter says this company's work is 'personally significant'
17 July
MS drugs delisting threat ends
But it comes with a sting in the tail. The PBAC will launch a review of how the drugs are being used on the PBS to be concluded by December
17 July
New PBS patient furore brewing
The Minister has put out one fire by keeping MS drugs on the PBS but another fight is brewing over access to a different life-changing treatment
17 July
Top redundancy pain points named
Mortgage stress and fear of finding work is plaguing those who have been laid off plus the other most popular stories this week
17 July Your Week in 5 Minutes
Ex-Bayer boss joins Astellas
While a GM is yet to be announced, a Head of Sales has been named becoming the newest member of the Australian Leadership Team
17 July
Who owns the next blockbuster?
The current top-valued R&D programs could rake in combined global sales of US$50M in 2032, if successfully launched
16 July
Aussie-first manufacturing facility opens
The opening of the new facility improves Australia's sovereign manufacturing capability and will reduce development time for radiopharmaceuticals
16 July
$100K fine over prescription drug
A pharmacy has been fined by the TGA less than six months after it issued a warning on illegal imports of a prescription drug
16 July
Aussie deal struck on biosimilar
Two pharmas have signed an agreement to commercialise a biosim, which may see a drug move closer to a PBS listing
16 July
Next on NEXT: A drug's life
The Summit will undertake something no pharma event in Australia has ever done before, putting industry in the driver's seat
16 July
Roche GM's tough line on Aussie TV
Roche Australia's General Manager Nic Horridge has branded a Govt-requested price cut as unrealistic and unreasonable on ABC TV
15 July